RxDoctor Payments Data

Nicole Cassler, MD

Dermatology · Tacoma, WANPI 1750585741

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,484 of the $11,740 with a category attached, or 80.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,011 and has fallen 51.3% since, to $1,954 in 2025. Among dermatology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,740in general payments, 2019–2025

Across 358 payments — averaging $32.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dermavant Sciences, Inc.$3K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Pfizer$951
  • Sun Pharmaceutical Industries Inc.$858
  • UCB, Inc.$758
  • plus $4K from 20 others

What the payments were for

  • Consulting fees$2,00017%
  • Travel & lodging$580%
  • Food & beverage$9,48481%
  • Education$1982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,740 in reported general payments places this provider in the 90th percentile of 323 dermatology providers in Washington.

See all dermatology providers in Washington

Medicare billing

Part B allowed, 2024
$203,337
Medicare patients
513
Services billed
2,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,380
Clobetasol Propionate86$3,541
Ketoconazole114$1,681
Metronidazole21$1,086
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc28$1,034
Doxycycline Monohydrate26$985
Triamcinolone Acetonide78$931
ValacyclovirValacyclovir Hcl26$568
Desonide17$562
Hydroxychloroquine Sulfate13$240
Nystatin17$215
Fluconazole20$188
Minoxidil12$183
Terbinafine Hcl13$154

Paid to pharmacies, not to this prescriber.

Other dermatology in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →